Cytokine removal in human septic shock: Where are we and where are we going?

Patrick M Honore, Eric Hoste, Zsolt Molnár, Rita Jacobs, Olivier Joannes-Boyau, Manu L N G Malbrain, Lui G Forni

Research output: Contribution to journalScientific reviewpeer-review

71 Citations (Scopus)


Although improving, the mortality from septic shock still remains high despite increased international awareness. As a consequence, much effort has focused on alternative treatment strategies in an effort to improve outcomes. The application of blood purification therapies to improve immune homeostasis has been suggested as one such method, but these approaches, such as high-volume continuous haemofiltration or cytokine and/or endotoxin removal, have enjoyed little success to date. More recently, the use of sorbent technologies has attracted much attention. These adsorbers are highly effective at removing inflammatory mediators, in particular, cytokines, from the bloodstream. This narrative review is the executive summary of meetings held throughout the 6th International Fluid Academy Days in Antwerp, Belgium (Nov 23-25, 2017), focusing on the current understanding regarding the use of such adsorbers in humans with septic shock. We followed a modified Delphi approach involving a combination of evidence appraisal together with expert opinion in order to achieve recommendations for practice and, importantly, future research.

Original languageEnglish
Article number56
JournalAnnals of Intensive Care
Issue number1
Publication statusPublished - 2019


Dive into the research topics of 'Cytokine removal in human septic shock: Where are we and where are we going?'. Together they form a unique fingerprint.

Cite this